John Chalmers AC's Publications

Mohammedi K, Harrap S, Mancia G et alii
History of lower-limb complications and risk of cancer death in people with type 2 diabetes

Journal articles
2021
Cardiovascular Diabetology
Jun M, Harris K, Heerspink H et alii
Variability in eGFR and the risk of major clinical outcomes in diabetes: post-hoc analysis from the ADVANCE trial.

Journal articles
2021
Diabetes Obes Metab
Ohkuma T, Chalmers J, Cooper M et alii
The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial.

Journal articles
2021
Diabetes Obes Metab
Zhou Z, Delcourt C, Xia C et alii
Low- versus Standard-dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.

Journal articles
2021
Neurology
Jeyam A, Colhoun H, McGurnaghan S et alii
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

Journal articles
2021
Diabetes care
Oshima M, Hara A, Toyama T et alii
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

Journal articles
2021
Kidney International Reports
Nanayakkara N, Curtis AJ, Heritier S et alii
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses

Journal articles
2021
Diabetologia
Minhas JS, Wang X, Lindley RI et alii
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial

Journal articles
2021
Journal of hypertension
Chen X, Li J, Anderson CS et alii
Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

Journal articles
2021
International Journal of Stroke
Song L, Wang X, Ouyang M et alii
Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study

Journal articles
2021
Stroke
Tham YK, Jayawardana KS, Alshehry ZH et alii
Novel lipid species for detecting and predicting atrial fibrillation in patients with type 2 diabetes

Journal articles
2021
Diabetes
Chow CK, Atkins ER, Billot L et alii
Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol

Journal articles
2021
American Heart Journal
Sandset EC, Wang X, Carcel C et alii
Sex differences in treatment, radiological features and outcome after intracerebral haemorrhage: Pooled analysis of Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage trials 1 and 2

Journal articles
2020
European Stroke Journal
Kim H, Wang D, Chalmers J et alii
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial

Journal articles
2020
Journal of Diabetes
Canoy D, Copland E, Ramakrishnan R et alii
Stratified effects of blood pressure-lowering treatment on long-term blood pressure: an individual patient-level meta-analysis involving 50 randomised trials and 334,219 participants

Conference Papers
2020
in EUROPEAN HEART JOURNAL
Chen C, Wang X, Chen X et alii
ASIANS VERSUS NON-ASIAN, DIFFERENCES IN CHARACTERISTIC, MANAGEMENT AND OUTCOMES FOR TPA-TREATED ACUTE ISCHEMIC STROKE PATIENTS IN THE ENCHANTED TRIAL

Conference Papers
2020
in INTERNATIONAL JOURNAL OF STROKE
Chen G, Wang X, Moullaali T et alii
INFLUENCE OF RENAL IMPAIRMENT ON OUTCOME BY HISTORY OF HYPERTENSION FOR THROMBOLYSIS-TREATED ACUTE ISCHEMIC STROKE: THE ENCHANTED TRIAL

Conference Papers
2020
in INTERNATIONAL JOURNAL OF STROKE
Jun M, Jardine M, Heerspink HL et alii
VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE

Conference Papers
2020
in NEPHROLOGY
Gorski M, Jung B, Li Y et alii
Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline.

Journal articles
2020
Kidney Int
Godolphin PJ, Bath PM, Algra A et alii
Cost-benefit of outcome adjudication in nine randomised stroke trials

Journal articles
2020
Clinical Trials
Ohkuma T, Peters SAE, Jun M et alii
Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study

Journal articles
2020
Diabetes
Chen X, Delcourt C, Sun L et alii
Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm

Journal articles
2020
Cerebrovascular Diseases
Wang X, Moullaali TJ, Li Q et alii
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients

Journal articles
2020
Stroke
Harris K, Oshima M, Sattar N et alii
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study

Journal articles
2020
Diabetologia
Hua X, Lung TWC, Woodward M et alii
Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

Journal articles
2020
Diabetic Medicine

John Chalmers AC's Publications

History of lower-limb complications and risk of cancer death in people with type 2 diabetes

Variability in eGFR and the risk of major clinical outcomes in diabetes: post-hoc analysis from the ADVANCE trial.

The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial.

Low- versus Standard-dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses

Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial

Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study

Novel lipid species for detecting and predicting atrial fibrillation in patients with type 2 diabetes

Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol

Sex differences in treatment, radiological features and outcome after intracerebral haemorrhage: Pooled analysis of Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage trials 1 and 2

Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial

Stratified effects of blood pressure-lowering treatment on long-term blood pressure: an individual patient-level meta-analysis involving 50 randomised trials and 334,219 participants

ASIANS VERSUS NON-ASIAN, DIFFERENCES IN CHARACTERISTIC, MANAGEMENT AND OUTCOMES FOR TPA-TREATED ACUTE ISCHEMIC STROKE PATIENTS IN THE ENCHANTED TRIAL

INFLUENCE OF RENAL IMPAIRMENT ON OUTCOME BY HISTORY OF HYPERTENSION FOR THROMBOLYSIS-TREATED ACUTE ISCHEMIC STROKE: THE ENCHANTED TRIAL

VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE

Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline.

Cost-benefit of outcome adjudication in nine randomised stroke trials

Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study

Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm

Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study

Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country